121 related articles for article (PubMed ID: 7168013)
1. Serum thyroglobulin levels in patients with bone metastases from an unknown primary site.
Shah DH; Krishna BA; Pradhan SA; Rao RS; Ganatra RD; Sharma SM
Tumori; 1982 Dec; 68(6):481-3. PubMed ID: 7168013
[TBL] [Abstract][Full Text] [Related]
2. Renal metastasis from papillary thyroid microcarcinoma.
Liou MJ; Lin JD; Chung MH; Liau CT; Hsueh C
Acta Otolaryngol; 2005 Apr; 125(4):438-42. PubMed ID: 15823819
[TBL] [Abstract][Full Text] [Related]
3. [A swelling of the sternum during respiration].
Nehme N; Alvarez M; Ollier S; Arlet P
Rev Med Interne; 2000 Dec; 21(12):1126-7. PubMed ID: 11191680
[No Abstract] [Full Text] [Related]
4. Biochemical characterization of serum thyroglobulin from patients with bone metastases from follicular carcinoma of the thyroid.
Kumar A; Shah DH; Thakare UR
Indian J Biochem Biophys; 1991 Jun; 28(3):198-202. PubMed ID: 1786970
[TBL] [Abstract][Full Text] [Related]
5. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma.
Dadparvar S; Krishna L; Brady LW; Slizofski WJ; Brown SJ; Chevres A; Micaily B
Cancer; 1993 Jun; 71(11):3767-73. PubMed ID: 8490927
[TBL] [Abstract][Full Text] [Related]
6. [A case of metastatic rib tumor from thyroid cancer confirmed by the presence of thyroglobulin].
Shinohara A; Fukuda K; Maeda K; Ogushi F; Sone S; Ogura T; Shinomiya S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1211-5. PubMed ID: 1753551
[TBL] [Abstract][Full Text] [Related]
7. Serum thyroglobulin in the investigation of patients presenting with metastases.
Edmonds CJ; Willis CL
Br J Radiol; 1988 Apr; 61(724):317-9. PubMed ID: 3370417
[TBL] [Abstract][Full Text] [Related]
8. Brain metastases from papillary adenocarcinoma of the thyroid.
Yousuf K; Archibald SD
J Otolaryngol; 2006 Dec; 35(6):366-72. PubMed ID: 17380829
[TBL] [Abstract][Full Text] [Related]
9. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
Arning G; Ehrenheim C; Schober O; Hundeshagen H
Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer.
Pacini F; Lari R; Mazzeo S; Grasso L; Taddei D; Pinchera A
Clin Endocrinol (Oxf); 1985 Oct; 23(4):405-11. PubMed ID: 4064348
[TBL] [Abstract][Full Text] [Related]
11. Serum thyroglobulin in the management of patients with thyroid cancer.
Barsano CP; Skosey C; DeGroot LJ; Refetoff S
Arch Intern Med; 1982 Apr; 142(4):763-7. PubMed ID: 7073416
[TBL] [Abstract][Full Text] [Related]
12. Undetectable serum thyroglobulin in a patient with metastatic follicular thyroid cancer.
Mertens IJ; De Klerk JM; Zelissen PM; Thijssen JH; Sie-Go DM; Han SH; Van Rijk PP
Clin Nucl Med; 1999 May; 24(5):346-9. PubMed ID: 10232475
[TBL] [Abstract][Full Text] [Related]
13. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood.
Biscolla RP; Cerutti JM; Maciel RM
J Clin Endocrinol Metab; 2000 Oct; 85(10):3623-7. PubMed ID: 11061512
[TBL] [Abstract][Full Text] [Related]
14. Sustained and diffuse 131I avid bone metastases with low thyroglobulin levels in a patient with papillary thyroid carcinoma.
Zhao CL; Qiu ZL; Chen LB; Yuan ZB; Luo QY
Clin Nucl Med; 2013 May; 38(5):375-7. PubMed ID: 23567283
[TBL] [Abstract][Full Text] [Related]
15. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
16. Serum thyroglobulin differentiated thyroid carcinoma: histological and metastatic classification.
Shah DH; Dandekar SR; Jeevanram RK; Kumar A; Sharma SM; Ganatra RD
Acta Endocrinol (Copenh); 1981 Oct; 98(2):222-6. PubMed ID: 7293654
[TBL] [Abstract][Full Text] [Related]
17. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
[TBL] [Abstract][Full Text] [Related]
18. [Radioimmunological methods in the diagnosis of metastases of thyroid cancer].
Lozinskaia IN; Vikman IaE
Med Radiol (Mosk); 1987 Jun; 32(6):6-9. PubMed ID: 3600228
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma.
Razfar A; Branstetter BF; Christopoulos A; Lebeau SO; Hodak SP; Heron DE; Escott EJ; Ferris RL
Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):120-5. PubMed ID: 20157055
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of blood thyroglobulin determination in patients with thyroid cancer].
Ikekubo K; Hamasaki T; Yamada A; Bito S; Tochio H; Saiki Y; Ito H; Morimoto Y; Akamizu T; Sawada K
Kaku Igaku; 1983 Apr; 20(3):313-9. PubMed ID: 6632358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
